Sharpe ratio
0.75Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
+26.09%1Y Absolute Return
-0.01%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTHFund 5Y annualised return | ₹12,38,791 | ₹7,32,612 | ₹5,06,179 | +20.66% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.18
₹1 Lakh since launch₹1.18 Lakh
Fund age13.9 yrs
Fund information
Scheme code119783
ISININF200K01UP2
BenchmarkBSE Healthcare TRI
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio1.04%
Exit loadExit load of 0.50% if redeemed within 15 days
Minimum SIP₹500 SIP
Return comparison
21st / 932 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +253.00% | — | — |
| 3M | +18.28% | — | — |
| 6M | +39.20% | — | — |
| 1Y | +26.09% | — | +4.16% |
| 3Y | +25.44% | — | +12.54% |
| 5Y | +20.66% | — | +10.04% |
| 10Y | +15.92% | — | — |
| Since Launch | +18.43% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.08Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
13.60%How much the fund’s returns fluctuate over time.
Moderate volatility
Returns can move up and down noticeably.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
0.60How well the fund rewarded investors relative to its biggest decline.
Good
Good return relative to the drawdowns experienced.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 36 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.72% |
| Divi's Laboratories Ltd | Healthcare | Equity | 7.46% |
| Ami Organics Ltd | Healthcare | Equity | 5.17% |
| Cipla Ltd | Healthcare | Equity | 5.07% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 4.98% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.74% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.58% |
| Laurus Labs Ltd | Healthcare | Equity | 4.04% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 3.86% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.65% |
Fund management
PR
Pradeep Kesavan
Since 2023 · Prior to joining SBI MF, he has worked with Elara Capital, Accenture Strategy, Morgan Stanley and 3i Infotech
Mr. Kesavan has done B.Com, MBA (Finance) and CFA
TA
Tanmaya Desai
Since 2012 · Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
Compare similar funds
No comparable category funds are available yet.
Summary
A high riskometer-risk equity scheme - sectoral/ thematic fund. Ahead of its category average over 3Y by 12.9 points. Healthcare makes up 96% — trouble in that sector hits the whole fund.
Strengths
- Ahead of its category average over 3Y by 12.9 points.
- Recovered from its worst fall in 3 months.
- Same fund manager for 14+ years — the strategy has not chopped and changed.
- Ranks 21 of 932 in its category over 1 year.
Weaknesses
- None
Ideal investor
- Needs a 5–7+ years horizon to ride out its high riskometer risk level.
- Good fit for SIPs — spreading purchases smooths out 13.6% volatility.
Risk drivers
- Healthcare makes up 96% — trouble in that sector hits the whole fund.